Delivery of genetic load during ex situ liver machine perfusion with potential for CRISPR-Cas9 gene editing: An innovative strategy for graft treatment.
Hepatobiliary & pancreatic diseases international : HBPD INT, 20(5): 503-505 PMID 33958293 DOI 10.1016/j.hbpd.2021.04.006
Abstract
This article has no abstract in PubMed.